Lund University Hospital

Lund SE-22181

1 studies enrolling now · 19 studies all time

What they study most

Alpha 1-Antitrypsin Deficiency, Aneurysmal Subarachnoid Hemorrhage, Autoimmune Diseases, Branch Retinal Vein Occlusion, COPD, Carcinoma, Non-small-cell Lung, Central Retinal Vein Occlusion, Cerebral Palsy, Coronary Artery Disease, Diabetic Macular Edema, Emphysema, Head and Neck Cancer

Studies at this site

• A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors — Recruiting now
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. — Completed
• Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma — Status unconfirmed
• Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma — Status unconfirmed
• Cerebral Palsy Hip Outcomes Project - International Multi-centre Study — Status unconfirmed
• Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping — Completed
• Clazosentan in Aneurysmal Subarachnoid Hemorrhage — Stopped early
• OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer — Completed
• S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML — Completed
• Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia — Completed
• Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma — Completed
• Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer — Completed
• Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension — Completed
• Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer — Stopped early
• SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries — Status unconfirmed
• Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
• Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon — Completed
• A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed